26 Aug - 2 min read

Dealing in securities and change in beneficial ownership

Dealing in securities and change in beneficial ownership

Dis-Chem Pharmacies Limited
(Incorporated in the Republic of South Africa)
(Registration number 2005/009766/06)
JSE share code: DCP
ISIN: ZAE000227831
(“Dis-Chem” or “the Company”)


Shareholders of Dis-Chem are referred to the announcements published on Tuesday, 24 August 2021 and
Wednesday, 25 August 2021 respectively relating to the election by the Saltzman family to sell a portion of
their current shareholding in Dis-Chem through their shareholding vehicle, Ivlyn Local Investment Holdings
Proprietary Limited (“Ivlyn”) by way of an accelerated bookbuild (“Bookbuild”).

Following strong demand, the Saltzman family raised a total of approximately R1.96 billion through the sale
of 64,506,336 Dis-Chem ordinary shares at a price of R30.30 per share. Post the Bookbuild, Ivlyn owns
approximately 45.2% of Dis-Chem’s issued share capital.

Dealings in securities

In compliance with sections 3.63 to 3.74 of the Listings Requirements of the JSE Limited (“JSE”), the following
information is disclosed:

Name of directors:                       Ivan Saltzman and Lynette Saltzman
Name of associate:                       Ivlyn
Class of securities:                     Dis-Chem ordinary shares
Number of shares:                        64,506,336
Price per share:                         R30.30
Value of transaction:                    R1.96 billion
Date of transaction:                     25 August 2021
Nature and extent of interest:           Indirect beneficial

Clearance for the above transaction was obtained in accordance with Dis-Chem’s trading policy.

Change in beneficial interest in securities

In compliance with Section 122(3) (b) of the Companies Act, 2008 (Act 71 of 2008), as amended (“Companies
Act”) and paragraph 3.83(b) of the Listings Requirements of the JSE, shareholders are advised that Ivlyn has
disposed of a beneficial interest in the securities of the Company, such that the total interest in the ordinary
shares of the company held by Ivlyn amounts to 45.2% (previously held 52.7% of the total number of
securities in issue).

As required in terms of section 122(3) (a) of the Companies Act, Dis-Chem will be filing the required notice
with the Takeover Regulation Panel.

26 August 2021

The Standard Bank of South Africa Limited

Date: 26-08-2021 10:02:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Dis-Chem Pharmacies Limited (JSE:DCP) when you join Listcorp.